# US 2021/0292716 A1 · D-xylose dehydrogenase from coryneform bacteria and process for preparing d-xylonate

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0292716 A1
- Document ID: US20210292716A1
- Status: Published application
- Kind: A1
- Application number: 17/258,832
- Filed: 2019-06-29
- Published: 2021-09-23
- Earliest claimed: 2018-07-11
- Assignees: Forschungszentrum Juelich GmbH
- Applicants: Forschungszentrum Juelich GmbH
- Inventors: Niklas Tenhaef; Stephan Noack; Christian Bruesseler; Jan Marienhagen
- Web page: https://patentgrep.com/patent/US20210292716A1

## CPC

- C12N 9/0006: {acting on CH-OH groups as donors (1.1)}
- C12N 1/205: Bacterial isolates
- C12P 7/42: Hydroxy-carboxylic acids
- C12Y 101/01175: D-Xylose 1-dehydrogenase (1.1.1.175)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES

## Abstract

A D-xylose dehydrogenase comprising an amino acid sequence that has at least 70% identity to the amino acid sequence according to SEQ ID NO. 2 or fragments thereof.

## Claims

### Claim 1

A D-xylose dehydrogenase comprising an amino acid sequence that has at least 70% identity to the amino acid sequence according to SEQ ID NO. 2 or fragments thereof.

### Claim 2 (depends on 1)

The D-xylose dehydrogenase according to claim 1, containing an amino acid sequence according to SEQ ID NO. 2 or fragments thereof.

### Claim 3 (depends on 1)

The D-xylose dehydrogenase according to claim 1, wherein the D-xylose dehydrogenase comprises an amino acid sequence encoded by a nucleic acid sequence containing at least 70% identity to the nucleic acid sequence according to SEQ ID NO. 1 or fragments or alleles thereof.

### Claim 4 (depends on 1)

The D-xylose dehydrogenase according to claim 1, wherein the D-xylose dehydrogenase comprises an amino acid sequence encoded by a nucleic acid sequence according to SEQ. ID NO. 1 or fragments or alleles thereof.

### Claim 5

A nucleic acid sequence,
wherein the nucleic acid sequence is
a) a nucleic acid sequence containing at least 70% identity to the nucleic acid sequence according to SEQ ID NO. 1 or fragments or alleles thereof,
b) a nucleic acid sequence which, under stringent conditions, hybridizes with a complementary sequence of a nucleic acid sequence according to SEQ ID NO. 1 or fragments or alleles thereof,
c) a nucleic acid sequence according to SEQ. ID NO. 1 or fragments or alleles thereof, or
d) a nucleic acid sequence encoding a D-xylose dehydrogenase corresponding to each of the nucleic acids according to a)-c) but which differs from these nucleic acid sequences according to a)-c) by the degeneracy of the genetic code or functionally neutral mutations.

### Claim 6 (depends on 1, 5)

The nucleic acid sequence according to claim 5,
wherein the functionality of one or more operatively linked IolR binding sites in the regulatory, non-coding region of the iolC gene cluster, containing iolG encoding a D-xylose dehydrogenase according to claim 1, is reduced or turned off, or one or more IolR binding sites are partially or completely deleted.

### Claim 7 (depends on 5)

The nucleic acid sequence according to claim 5,
wherein the nucleic acid sequence has one or more nucleotide substitutions or nucleotide deletions in the operatively linked IolR binding sites of the iolC gene cluster, preferably selected from the group of nucleic acid sequences according to SEQ ID NO. 7 and SEQ ID NO. 8 or fragments or alleles thereof.

### Claim 8 (depends on 5)

The nucleic acid sequence according to claim 5,
wherein the nucleic acid sequence it has one or more nucleotide substitutions or nucleotide deletions in the operatively linked IolR binding sites of the iolC gene cluster, preferably selected from the group of nucleic acid sequences according to SEQ ID NO. 63 and SEQ ID NO. 64 or fragments or alleles thereof.

### Claim 9 (depends on 1)

The D-xylose dehydrogenase according to claim 1,
isolated from Corynebacterium, Brevibacterium, Corynebacterium glutamicum, Corynebacterium acetoglutamicum, Corynebacterium thermoaminogenes, Brevibacterium flavum, Brevibacterium lactofermentum, or Brevibacterium divaricatum.

### Claim 10 (depends on 1)

The D-xylose dehydrogenase according to claim 1, isolated from Corynebacterium glutamicum ATCC13032, Corynebacterium acetoglutamicum ATCC15806, Corynebacterium acetoacidophilum ATCC13870, Corynebacterium thermoaminogenes FERM BP-1539, Brevibacterium flavum ATCC 14067, Brevibacterium lactofermentum ATCC13869, or Brevibacterium divaricatum ATCC14020.

### Claim 11 (depends on 1)

A coryneform bacterial cell, wherein the coryneform bacterial cell has an enhanced expression and/or increased activity of a homologous D-xylose dehydrogenase according to claim 1 or fragments thereof.

### Claim 12 (depends on 11)

The coryneform bacterial cell according to claim 11,
wherein the coryneform bacterial cell comprises a first nucleic acid sequence, wherein the first nucleic acid sequence is
a) a nucleic acid sequence containing at least 70% identity to the nucleic acid sequence according to SEQ ID NO. 1 or fragments or alleles thereof,
b) a nucleic acid sequence which, under stringent conditions, hybridizes with a complementary sequence of a nucleic acid sequence according to SEQ ID NO. 1 or fragments or alleles thereof,
c) a nucleic acid sequence according to SEQ. ID NO. 1 or fragments or alleles thereof, or
d) a nucleic acid sequence encoding a D-xylose dehydrogenase corresponding to each of the nucleic acids according to a)-c) but which differs from these nucleic acid sequences according to a)-c) by the degeneracy of the genetic code or functionally neutral mutations, and wherein the functionality of one or more operatively linked IolR binding sites in the regulatory, non-coding region of the nucleic acid sequence encoding the D-xylose dehydrogenase in the iolC gene cluster is reduced or turned off, or one or more IolR binding sites are partially or completely deleted.

### Claim 13 (depends on 11)

The coryneform bacterial cell according claim 11,
wherein the coryneform bacterial cell has a nucleic acid sequence with one or more nucleotide substitutions or nucleotide deletions in the operatively linked IolR binding sites of the iolC gene cluster.

### Claim 14 (depends on 11)

The coryneform bacterial cell according to claim 11,
wherein the coryneform bacterial cell has a nucleic acid sequence with one or more nucleotide substitutions or nucleotide deletions in the operatively linked IolR binding sites of the iolC gene cluster.

### Claim 15 (depends on 11)

The coryneform bacterial cell according to claim 11,
wherein the coryneform bacterial cell has a nucleic acid sequence with one or more nucleotide substitutions or nucleotide deletions in the operatively linked IolR binding sites of the iolT1 gene.

### Claim 16 (depends on 11)

The coryneform bacterial cell according to claim 11, wherein the coryneform bacterial cell is Corynebacterium, Brevibacterium, Corynebacterium glutamicum, Corynebacterium acetoglutamicum, Corynebacterium thermoaminogenes, Brevibacterium flavum, Brevibacterium lactofermentum, or Brevibacterium divaricatum.

### Claim 17 (depends on 11)

The coryneform bacterial cell according to claim 11,
wherein the coryneform bacterial cell is Corynebacterium glutamicum ATCC13032, Corynebacterium acetoglutamicum ATCC15806, Corynebacterium acetoacidophilum ATCC 13870, Corynebacterium thermoaminogenes FERM BP-153 9, Brevibacterium flavum ATCC14067, Brevibacterium lactofermentum ATCC13869, or Brevibacterium divaricatum ATCC14020.

### Claim 18 (depends on 11)

The coryneform bacterial cell according to claim 11,
wherein the increased copy number of a nucleic acid sequence encoding D-xylose dehydrogenase is chromosomally encoded.

### Claim 19 (depends on 11)

The coryneform bacterial cell according to claim 11,
wherein the coryneform bacterial cell is not recombinantly modified.

### Claim 20 (depends on 11)

The coryneform bacterial cell according to claim 11,
wherein the increased copy number of a nucleic acid sequence encoding D-xylose dehydrogenase is extra-chromosomally encoded.

### Claim 21 (depends on 12)

The coryneform bacterial cell according to claim 12,
a) wherein the activity of the D-xylose dehydrogenase is increased,
b) wherein the first nucleic acid sequence is enhancedly expressed,
c) wherein the coryneform bacterial cell comprises a second nucleic acid sequence that encodes a myo-inositol/proton symporter (IolT1) according to SEQ ID NO. 3 or fragments or alleles thereof, and wherein the second nucleic acid sequence is enhancedly expressed,
d) wherein the myo-inositol/proton symporter IolT1 encoded by the second nucleic acid sequence comprises an amino acid sequence according to SEQ ID NO. 4 or fragments thereof, and wherein the activity of the IolT1 is increased,
e) wherein the second nucleic acid sequence encoding a myo-inositol/proton symporter (IolT1) comprises one or more nucleotide substitutions or nucleotide deletions in the operatively linked IolR binding sites of the iolT1 gene,
f) wherein the coryneform bacterial cell comprises a third nucleic acid sequence that encodes a myo-inositol/proton symporter (IolT2) according to SEQ ID NO. 5 or fragments or alleles thereof, and wherein the third nucleic acid sequence is enhancedly expressed,
g) wherein the myo-inositol/proton symporter IolT2 encoded by the third nucleic acid sequence comprises an amino acid sequence according to SEQ ID NO. 6 or fragments thereof, and wherein the activity of the IolT2 is increased,
h) wherein the second and third nucleic acid sequences encoding myo-inositol/proton symporters IolT1/2 are enhancedly expressed,
i) wherein the activity of both myo-inositol/proton symporters IolT1/2 is increased,
j) having the nucleic acid sequence encoding the D-xylose dehydrogenase comprises one or more nucleotide substitutions or nucleotide deletions in the operatively linked IolR binding sites of the iolC gene cluster, or
k) any combination of a)-j.

### Claim 22

A process for preparing D-xylonate, comprising the steps of:
a) providing a solution containing water and a C5 carbon source,
b) culturing a coryneform bacterial cell in the presence of the solution according to step a) to form D-xylonate, wherein the cornyneform bacterial cell comprises a nucleic acid sequence encoding a homologous D-xylose dehydrogenase, and wherein the expression of the nucleic acid sequence is enhanced and/or the activity of a homologous D-xylose dehydrogenase is increased, and
c) optionally, isolating and/or preparing of D-xylonate from the solution.

### Claim 23 (depends on 22)

The process according to claim 22, wherein the coryneform bacterial cell has an enhanced expression and/or increased activity of the homologous D-xylose dehydrogenase.

### Claim 24 (depends on 22)

The process according to claim 22,
wherein the D-xylose dehydrogenase in step b) comprises an amino acid sequence of at least 70% identity to the amino acid sequence according to SEQ ID NO. 2 or fragments thereof, and/or is encoded by a nucleic acid sequence which has at least 70% identity to the nucleic acid sequence according to SEQ ID NO. 1 or fragments or alleles thereof.

### Claim 25 (depends on 22)

The process according to claim 22,
wherein the C5 carbon source is
a) oligosaccharides or polysaccharides containing D-xylose units,
b) D-xylose,
c) biomass containing lignocellulose, cellulose, or hemicellulose, the hydrolysate thereof or extract obtained therefrom containing D-xylose units, or
d) any combination of a)-c).

### Claim 26 (depends on 22)

The process according to claim 22,
wherein the C5 carbon source is bagasse.

### Claim 27 (depends on 22)

The process according to claim 22,
wherein the culturing takes place discontinuously or continuously, preferably in batch, fed batch, repeated fed batch mode or as a one-pot hydrolysis fermentation process.

### Claim 28 (depends on 22)

The process according to claim 22,
wherein the solution comprises D glucose in addition to D-xylose.

### Claim 29 (depends on 22)

The process according to claim 22,
wherein the culturing takes place in fed batch mode.

### Claim 30 (depends on 22)

The process according to claim 22,
wherein the coryneform bacterial cell is not recombinantly modified.

### Claim at position 31

-37. (canceled)
